Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.34 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.32 |
| ▸ | FDPS | P14324 | 3/20 | 0.32 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.32 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3869536 | 0.98 | OPRM1 (0.39) | OPRM1LMNADNM1SMPD1FDPS | |
| SCHEMBL3704480 | 0.91 | DNM1 (0.32) | OPRM1DNM1 | |
| SCHEMBL16909998 | 0.90 | OPRM1 (0.34) | OPRM1LMNADNM1SMPD1ZDHHC7 | |
| SCHEMBL16909965 | 0.86 | LMNA (0.34) | OPRM1LMNADNM1SMPD1TSHR | |
| SCHEMBL16910000 | 0.86 | LMNA (0.34) | OPRM1LMNADNM1SMPD1TSHR | |
| SCHEMBL435568 | 0.81 | ZDHHC7 (0.37) | OPRM1LMNADNM1SMPD1TSHR | |
| SCHEMBL2580819 | 0.78 | OPRM1 (0.41) | OPRM1LMNADNM1SMPD1TSHR | |
| SCHEMBL1616000 | 0.78 | OPRM1 (0.41) | OPRM1LMNADNM1SMPD1TSHR | |
| SCHEMBL4338991 | 0.78 | OPRM1 (0.41) | OPRM1LMNADNM1SMPD1TSHR | |
| SCHEMBL1109616 | 0.78 | OPRM1 (0.41) | OPRM1LMNADNM1SMPD1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12145937-B2 | Process for preparing bicyclic guanidines | WACKER CHEMIE AG (DE) | 2024-11-19 | — | — | US | claimed |
| US-9828297-B2 | Anticorrosion agent for reinforced concrete and corrosion preventing method | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-11-28 | — | — | US | claimed |
| US-20160280611-A1 | ANTICORROSION AGENT FOR REINFORCED CONCRETE AND CORROSION PREVENTING METHOD | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-09-29 | — | — | US | claimed |
| EP-3072858-A1 | ANTICORROSION AGENT FOR REINFORCED CONCRETE AND CORROSION PREVENTING METHOD | Shin-Etsu Chemical Co., Ltd. (JP) | 2016-09-28 | — | — | EP | claimed |
| US-20150299540-A1 | SPECIFIC AMINOALKYL-FUNCTIONAL ALKOXYSILOXANE OLIGOMER MIXTURES, PROCESS FOR PRODUCTION THEREOF AND USE THEREOF | EVONIK INDUSTRIES AG (DE) | 2015-10-22 | — | — | US | claimed |
| EP-2421874-B1 | COMPOSITION CONTAINING QUATERNARY AMINO-FUNCTIONAL ORGANOSILICON COMPOUNDS AND PRODUCTION AND USE THEREOF | EVONIK DEGUSSA GMBH (DE) | 2015-09-30 | — | — | EP | claimed |
| US-8979996-B2 | Composition containing quaternary amino-functional organosilicon compunds and production and use thereof | EVONIK DEGUSSA GMBH (DE) | 2015-03-17 | — | — | US | claimed |
| WO-2014167388-A1 | A SURFACE PROTECTION MATERIAL AND A PRODUCTION METHOD THEREOF | AK-KIM KIMYA SANAYI VE TICARET ANONIM SIRKETI (TR) | 2014-10-16 | — | — | WO | claimed |
| US-20140208981-A1 | COMPOSITION CONTAINING QUATERNARY AMINO-FUNCTIONAL ORGANOSILICON COMPOUNDS AND PRODUCTION AND USE THEREOF | EVONIK DEGUSSA GMBH (DE) | 2014-07-31 | — | — | US | claimed |
| US-8728225-B2 | Composition containing quaternary amino-functional organosilicon compounds and production and use thereof | EVONIK DEGUSSA GMBH (DE) | 2014-05-20 | — | — | US | claimed |
| US-20120037040-A1 | COMPOSITION CONTAINING QUATERNARY AMINO-FUNCTIONAL ORGANOSILICON COMPOUNDS AND PRODUCTION AND USE THEREOF | EVONIK DEGUSSA GMBH (DE) | 2012-02-16 | — | — | US | claimed |
| EP-1347024-B1 | Coating composition drying in the air containing silane | EVONIK DEGUSSA GMBH (DE) | 2009-03-11 | — | — | EP | claimed |
| US-7026398-B2 | Air-drying silane coating compositions | DEGUSSA AG (DE) | 2006-04-11 | — | — | US | claimed |
| EP-1193302-B1 | Paint, laquer, contaminants, bioorganisms, oil, water and/or soil repellent coating | DEGUSSA (DE) | 2005-11-23 | — | — | EP | claimed |
| US-6641870-B2 | Applying organosiloxane formulation to substrate to produce protective coating on substrate | DEGUSSA AG (DE) | 2003-11-04 | — | — | US | claimed |
| US-20030186066-A1 | AIR-DRYING SILANE COATING COMPOSITIONS | DEGUSSA AG (DE) | 2003-10-02 | — | — | US | claimed |
| US-20020037370-A1 | Ink, paint, pollutant, bioorganism, oil, water and / or dirt repellent coating | DEGUSSA AG (DE) | 2002-03-28 | — | — | US | claimed |
| EP-0712901-B1 | Flame retardant polycarbonate moulding compositions | BAYER AG (DE) | 1999-03-10 | — | — | EP | claimed |
| US-12595337-B2 | Cross-linkable compositions based on organyl oxysilane-terminated polymers | WACKER CHEMIE AG (DE) | 2026-04-07 | — | — | US | disclosed |
| US-5100981-A | PROCESS FOR THE PREPARATION OF A POLYPROPYLENE | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12145937-B2 | Process for preparing bicyclic guanidines | SMOX, CYP4X1, CDY1; CDY1B | OPRM1 78/4885LMNA 476/4885DNM1 2538/4885 |
| US-12595337-B2 | Cross-linkable compositions based on organyl oxysilane-terminated polymers | SMC3, SMC2, SMC1A | OPRM1 483/4885LMNA 694/4885DNM1 4254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.